New Treatment For Pulmonary Hypertension

Rejekine. Pulmonary hypertension may not be too familiar in our ears, when the disease is a fatal disease that strikes many people, especially in the productive age. Please note, the number of events in women is two to three times more than in males. For the case of primary pulmonary hypertension, the disease is inherited or related to genetic factors.

Despite widespread pulmonary hypertension is currently less known, but estimated around 1-2 million people per year diagnosed with the disease. In Indonesia, pulmonary hypertension is underdiagnosed and less treatment because of lack of public awareness about this disease. Those who suffer from pulmonary hypertension is generally not treated, patients are not even aware that they are exposed to the dangerous disease.

Another constraint is quite a lot of symptoms associated with pulmonary hypertension did not specifically lead to pulmonary hypertension, so do not be surprised if the diagnosis of the disease is quite difficult.

If pulmonary hypertension is left untreated, the life expectancy, especially for patients with primary pulmonary hypertension (pulmonary hypertension of unknown origin) are generally less than three years. But with technological advances, pulmonary hypertension therapy are now able to use inhaled medication is known to be beneficial to increase life expectancy and also relieve symptoms of pulmonary hypertension